Turnstone Biologics (TSBX) Earnings Date & Reports
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TSBX is expected to report earnings to rise 33.33% to -68 cents per share on August 13
Q2'25
Est.
$-0.68
Q1'25
Beat
by $0.17
Q4'24
Beat
by $0.20
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.15
The last earnings report on May 09 showed earnings per share of -50 cents, beating the estimate of -68 cents. With 236.69K shares outstanding, the current market capitalization sits at 8.11M.